Cargando…
2238. Immunogenicity and safety of four- vs. three-standard doses HBV vaccination in HIV-infected adults with isolated anti-HBc antibody
BACKGROUND: HIV-infected patients have decreased serological response to HBV vaccination with faster decline of protective antibody (Ab) titer. In those with isolated anti-HBc Ab, the role of vaccination remains controversial. We, therefore, conducted this study aimed to determine immunogenicity and...
Autores principales: | Laksananun, Nattinee, Chaiwarith, Romanee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252558/ http://dx.doi.org/10.1093/ofid/ofy210.1891 |
Ejemplares similares
-
Immunogenicity and safety of 4 vs. 3 standard doses of HBV vaccination in HIV-infected adults with isolated anti-HBc antibody
por: Laksananun, Nattinee, et al.
Publicado: (2019) -
Comparison of Immunogenicity and Safety of Four Doses and Four Double Doses vs. Standard Doses of Hepatitis B Vaccination in HIV-Infected Adults: A Randomized, Controlled Trial
por: Chaiklang, Kanokporn, et al.
Publicado: (2013) -
2231. Long-Term Immunogenicity of Four Doses and Four Double Doses vs. Standard Doses of Hepatitis B Vaccination in HIV-Infected Adults: An Extension of a Randomized Controlled Trial
por: Chaiwarith, Romanee, et al.
Publicado: (2018) -
Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial
por: Chaiwarith, Romanee, et al.
Publicado: (2019) -
Isolated Anti-HBc and Occult HBV Infection in Dialysis Patients
por: Ramezani, Amitis, et al.
Publicado: (2014)